Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.06K Sell
67
-139
-67% -$16K ﹤0.01% 88
2025
Q4
$21.7K Sell
206
-7
-3% -$657 ﹤0.01% 71
2025
Q3
$17.9K Sell
213
-72
-25% -$5.93K ﹤0.01% 66
2025
Q2
$22.5K Sell
285
-371,442
-100% -$29.5M ﹤0.01% 62
2025
Q1
$33.4M Buy
371,727
+1,638
+0.4% +$153K 0.89% 32
2024
Q4
$36.8M Buy
370,089
+59,386
+19% +$6.12M 0.94% 30
2024
Q3
$35.3M Sell
310,703
-1,407
-0.5% -$167K 0.87% 35
2024
Q2
$38.6M Sell
312,110
-10,563
-3% -$1.36M 1% 29
2024
Q1
$42.6M Sell
322,673
-2,860
-0.9% -$353K 1.1% 21
2023
Q4
$35.5M Sell
325,533
-8,223
-2% -$854K 0.97% 27
2023
Q3
$34.4M Buy
333,756
+26,921
+9% +$2.9M 1.03% 23
2023
Q2
$35.4M Buy
+306,835
New +$34.8M 1.04% 25
2023
Q1
Sell
-373,738
Closed -$40.4M 31
2022
Q4
$41.5M Buy
373,738
+22,997
+7% +$2.35M 1.36% 15
2022
Q3
$30.2M Buy
350,741
+350,710
+1,131,323% +$31.3M 1.01% 30
2022
Q2
$2.83K Buy
+31
New +$2.75K ﹤0.01% 80
2022
Q1
Sell
-19
Closed -$1.5K 79
2021
Q4
$1.46K Buy
+19
New +$1.51K ﹤0.01% 96
2021
Q3
Hold
0
86
2021
Q2
Hold
0
78
2019
Q4
Sell
-27
Closed -$2.19K 70
2019
Q3
$2.19K Buy
+27
New +$2.16K ﹤0.01% 59

Other funds holding MRK

WestEnd Advisors's MRK Position: Q1 2026 in Review

WestEnd Advisors reduced its Merck (MRK) stake by 67% in Q1 2026, selling an estimated $16K and leaving 67 shares worth $8.06K. The position accounts for ﹤0.01% of the portfolio, ranked #88.

WestEnd Advisors first reported a position in MRK in Q3 2019 and has held it in 17 quarters since. The position peaked at $42.6M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • WestEnd Advisors held 67 shares of Merck worth $8.06K as of Q1 2026.
  • WestEnd Advisors sold 139 Merck shares in Q1 2026, an estimated $16K.
  • Merck made up ﹤0.01% of WestEnd Advisors's portfolio in Q1 2026, its #88 holding.
  • WestEnd Advisors first reported a position in Merck in Q3 2019 and has held it in 17 quarters since.
  • WestEnd Advisors's Merck position peaked at $42.6M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on WestEnd Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.